March 2010
Dear Colleagues:
Welcome to the March issue of Psychiatry 2010. In this month’s “Trend Watch,” the authors explore the penetration of generic atypical antipsychotics in the United States market before and after the availability of generic risperidone. Based on this analysis, generic penetration into the atypical antipsychotic market has grown from three percent to more than 25 percent. An expert commentary by Peter Buckley, MD, Professor and Chairman, Department of Psychiatry, Medical College of Georgia, Augusta, Georgia, is provided.
Read the rest of this article »
Posted in Editor's Message: Issue Highlights | No Comments »







